Ann: BIT225 Reverses HIV-Induced Impairment of the Immune System, page-36

If they don't raise soon I don't see how they can further their new trial and the IND. The company are not funded for 009. Why would they delay the CR when all it means is more delays for the IND, the new trial
and BIT314. Perhaps another pump first but everyone bails at twelve cents..... IMO because they know that Michelle is hunting around for a sophisticated investor based CR and SPP.

I am waiting for info on the proposed trial and the funding to be secured.

also waiting for SVR12 from the G3 co-infected.

Of course this is all my opinion only.